← Back to Search

Behavioral Intervention

Sleep/Circadian Friendly for Delirium

N/A
Waitlist Available
Led By Garth R Swanson, MD
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at study completion, an average of 5-7 days
Awards & highlights

Study Summary

This trial will test whether better sleep leads to better recovery for people in the ICU.

Eligible Conditions
  • Delirium
  • Critical Illness
  • Circadian Dysregulation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study completion, an average of 5-7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and at study completion, an average of 5-7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hospital Readmission Rate
Length of Stay in ICU
Overall Hospital Length of Stay
+2 more
Secondary outcome measures
Concentration of 6-sulphatoxymelatonin (aMT6s)
Concentration of Interleukin-6 (IL-6) and interleukin-10 (IL-10)
Concentration of Lipopolysaccharide binding protein (LBP)
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sleep/Circadian FriendlyExperimental Treatment1 Intervention
initiation of sleep/circadian rhythm friendly intervention the first night spent in MICU after enrollment until patient transfers/discharges, ceases participation, or meets exclusion criteria.
Group II: Usual CareActive Control1 Intervention
Usual care within intensive care unit
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sleep/Circadian Friendly
2017
N/A
~60

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
421 Previous Clinical Trials
163,180 Total Patients Enrolled
1 Trials studying Delirium
263 Patients Enrolled for Delirium
Garth R Swanson, MDPrincipal InvestigatorRush University Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the major aims of this research project?

"The primary endpoint of this trial, estimated for completion in 5-7 days, is the Rate of Delirium. Secondary objectives consist of measuring Concentration of Interleukin-6 (IL-6) and interleukin-10 (IL-10) from a 2mL plasma sample collected during morning routine care lab draw; monitoring Overnight Sound Intensity Levels with SDL 600 industrial decibel monitors; and tracking Overnight Light Intensity Exposure with specialized medical lux meters."

Answered by AI

Are there any openings for enrollees in this trial at the moment?

"From the clinicaltrials.gov platform, it appears that this medical trial is no longer actively seeking participants; with its last amendment being on July 6th 2022 and first listing appearing February 27th 2017. However, there are currently 328 other studies accepting patient applications in real-time."

Answered by AI

Is it possible for me to volunteer in this research endeavor?

"This experiment seeks to recruit 61 participants who are aged between 18 and 99, and present with delirium."

Answered by AI

Does the age restriction for participating in this research permit individuals below 35 years of age?

"As indicated by the requirements, participants of this medical trial must be aged 18 or above and no older than 99."

Answered by AI
~6 spots leftby Apr 2025